Blog
RSS FeedPosted by Michael Wonder on 11 Apr 2025
13,000 people to benefit from new insulin medicine
11 April 2025 - Pharmac will fund a new type of insulin for people with diabetes, branded as Ryzodeg, from ...
Posted by Michael Wonder on 10 Apr 2025
Pfizer wins Korea nod for paediatric arthritis use of oral JAK inhibitor Xeljanz
7 April 2025 - Pfizer Korea has won national reimbursement for its oral JAK inhibitor Xeljanz (tofacitinib), expanding access to ...
Posted by Michael Wonder on 10 Apr 2025
PHARMAC to fund medicines for blood cancers, inflammatory bowel disease, eczema and arthritis
10 April 2025 - More New Zealanders will have access to medicines for blood cancers, bowel diseases, eczema and arthritis, ...
Posted by Michael Wonder on 03 Apr 2025
GSK Korea's long-acting HIV injection therapy gains insurance benefit
1 April 2025 - GSK Korea said its long-acting injectable HIV-1 combination treatment, Vocabria (cabotegravir 600 mg) and Rekambys (rilpivirine ...
Posted by Michael Wonder on 27 Mar 2025
New and expanded cheaper medicines
27 March 2025 - Australians with Cushing’s syndrome, retinal vein occlusion and psoriatic arthritis, leukaemia, and women needing contraception and menopause ...
Posted by Michael Wonder on 17 Mar 2025
Government delivering even more choice for women's contraception, endometriosis, and IVF journeys
16 March 2025 - The Government is delivering even more choice for Australian women with new and amended listings for contraception, ...
Posted by Michael Wonder on 11 Mar 2025
PHARMAC funds new oral contraceptive pill
11 March 2025 - PHARMAC has decided to fund a new progestogen only oral contraceptive pill called desogestrel (Cerazette). ...
Posted by Michael Wonder on 10 Mar 2025
Life changing new drug available for elderly Australians with devastating eye condition
9 March 2025 - A life changing new drug is now available on the PBS for elderly Australians with a ...
Posted by Michael Wonder on 04 Mar 2025
Roche Korea’s multiple sclerosis drug scores reimbursement
4 March 2025 - Roche Korea said its multiple sclerosis treatment, Ocrevus (ocrelizumab), started receiving reimbursement from last Saturday. ...
Posted by Michael Wonder on 03 Mar 2025
Amyloid cardiomyopathy drug Vyndamax to get health insurance from March
28 February 2025 - Vyndamax (tafamidis), a transthyretin amyloid cardiomyopathy medicine that has experienced difficulties getting on the health insurance ...
Posted by Michael Wonder on 03 Mar 2025
Cushing’s disease: drug added to PBS
2 March 2025 - Australians suffering from the debilitating condition Cushing’s disease have scored a huge win after a vital ...
Posted by Michael Wonder on 03 Mar 2025
New Zealand Pharmaceutical Schedule - 1 March 2025
1 March 2025 - The March 2025 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 02 Feb 2025
Life-saving lung cancer drug added to PBS, slashing price from $10,000 a month to $30 per script
1 February 2025 - Australians diagnosed with a rare form of lung cancer will now have access to a life-saving ...
Posted by Michael Wonder on 02 Feb 2025
Cheaper medicine for lung cancer patients
2 February 2025 - The Australian Government is listing Retevmo (selpercatinib) on the PBS for the first time to treat advanced ...
Posted by Michael Wonder on 01 Feb 2025
Schedule of Pharmaceutical Benefits - 1 February 2025
1 February 2025 - The February 2025 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...